CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Janel Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Janel Corp
80 EIGHTH AVENUE
Phone: (718) 527-3800p:718 527-3800 NEW YORK, NY  10011  United States Ticker: JANLJANL

Business Summary
Janel Corporation is a holding company. The Company operates through three segments: Logistics, Life Sciences and Manufacturing. The Company's Logistics segment consists of various wholly owned subsidiaries. Its Logistics segment is a non-asset based, full- service provider of cargo transportation logistics management services, including freight forwarding via air, ocean and land-based carriers, customs brokerage services, warehousing and distribution services, trucking, and other logistics services. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. The Manufacturing segment consists of Indco, Inc. (Indco), subsidiary of the Company, which manufactures and distributes mixing equipment and apparatus for specific applications within various industries. Indco serves small- to mid-sized businesses.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20249/30/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer DarrenSeirer 48 1/1/2023 1/1/2023
Vice Chairman of the Board JohnEidinger 42 1/1/2023 1/1/2023
Chief Financial Officer, Treasurer, Company Secretary, Principal Financial Officer and Principal Ac Joseph R.Ferrara 59 2/15/2024 2/15/2024
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Antibodies, Inc.
Aves Labs, Inc.
ECM Biosciences LLC
10 additional Business Names available in full report.

General Information
Number of Employees: 316 (As of 9/30/2023)
Outstanding Shares: 1,186,354 (As of 8/2/2024)
Shareholders: 59
Stock Exchange: OTC
Federal Tax Id: 861005291
Fax Number: (718) 527-1689


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024